Joshua T Lizer

Title: Innovations by Joshua T Lizer in SARS-CoV-2 Detection

Introduction

Joshua T Lizer is an accomplished inventor based in Augusta, MI (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of SARS-CoV-2 antibodies. His innovative work has the potential to enhance the understanding and management of COVID-19 in both humans and animals.

Latest Patents

Lizer holds a patent for a lateral flow device designed for detecting SARS-CoV-2 antibodies in human and animal samples. This invention provides a method for identifying antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in bodily fluid samples. The test involves contacting the sample with a conjugate that includes a recombinant SARS-CoV-2 spike protein antigen, which is conjugated to a detection agent. An antigen-antibody complex is formed, captured with an Fc-binding molecule, and subsequently detected.

Career Highlights

Joshua T Lizer is currently associated with Zoetis Services LLC, where he applies his expertise in developing innovative diagnostic solutions. His work is crucial in addressing the challenges posed by infectious diseases, particularly in the context of the ongoing pandemic.

Collaborations

Lizer collaborates with notable colleagues, including Jason J Workman and James P Gillies, who contribute to the advancement of research and development in their field.

Conclusion

Joshua T Lizer's contributions to the detection of SARS-CoV-2 antibodies exemplify the impact of innovation in medical diagnostics. His work not only aids in the fight against COVID-19 but also showcases the importance of collaboration in scientific research.